ArticleAfrican health sciences2025

Phosphodiesterase 4 inhibitor combined with secukinumab relieves clinical symptoms in patients with psoriasis via regulating p38MAPK activation and the immune response inflammation.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.